SR-1848

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameSR-1848
Drug Alias Nameliver receptor homolog 1 inhibitor (The Scripps Research Institute)SR-1848
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNuclear receptor subfamily 5 group A member 2 antagonists
TargetsNuclear receptor subfamily 5 group A member 2
Therapy Area/IndicationsPancreatic NeoplasmsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesThe Scripps Research Institute Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesThe Scripps Research Institute Inc
Active IndicationsN/A
Inactive IndicationsPancreatic NeoplasmsBreast Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A